Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis
Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis have?
Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis has 3 citations in the OpenAlex counts PICO Portal stores.
When was Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis published?
Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis has 2024 year in the PICO Portal index.
What is the open-access status of Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis?
Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis has hybrid oa status in the PICO Portal index.
What is the DOI of Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis?
The DOI for Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis is on the source record.
What is the PMID of Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis?
The PMID for Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis is on the source record.
What is the OpenAlex record for Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis?
The OpenAlex for Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis is on the source record.